How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

EV localisation policy should strengthen industry, not restrict competition
Bintulu Port expects positive cargo throughput growth in 2026
Teladan 2Q net profit jumps 42% to RM9.3mil
DNeX 2Q net profit rises 33% to RM26.6mil
Bank Islam announces retirement of chairman Ismail Bakar
Skyworld posts better earnings for 1Q
Pesona Metro’s 2Q net profit rises 47%, revenue hits record high
Sarawak Plantation sees stable CPO prices amid growing biofuel demand
SunCon secures RM1.04bil MEP fit-out works from US tech firm
PA Resources hits record 4Q revenue, net profit triples

Others Also Read